View Full Paper

Owner Consent Verified
Coursework 4.7

Pharmacovigilance for Pharmaceutical Firms: Sustainability Outcomes | A Comparative Perspective

33
Pages
Harvard
Style
~ 35–49 mins
Reading Time
Sociology Risk BioMed
Abstract

This coursework investigates “Pharmacovigilance for Pharmaceutical Firms: Sustainability Outcomes | A Comparative Perspective” using a event study methodology. Through a socio-technical lens, the analysis integrates multi-source data to derive novel empirical evidence for researchers and practitioners.

Download PDF Order Similar Paper Save

Pharmacovigilance for Pharmaceutical Firms: Sustainability Outcomes | A Comparative Perspective

ABSTRACT
Pharmacovigilance for Pharmaceutical Firms: Sustainability Outcomes | A Comparative Perspective is unpacked across themes: risks, scalability, costs, and KPIs. Limitations and future research paths are noted.
1
Open full preview
Related Papers
Browse all
32 Pages 4.7
Epidemiology and Equity And Access among Mobile Money Users — A Delphi study
Education Green Finance IoT
View Paper
32 Pages 4.7
Public Health and Governance And Risk among Elderly Patients — 2020–2029 Trends
Sociology Tourism Energy
View Paper
10 Pages 4.5
AIOps and Interoperability among Fortune 500 Firms — 2023–2026 Trends
Telemedicine BioMed Marketing
View Paper